Dale Broadrick, 10% Owner at BioRestorative Therapies, Inc. (BRTX), bought 6,200 shares at $2.95 ($18K) on 2023-02-22, disclosed to the SEC on 2023-03-03.
Open-market purchase of $18k BRTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.77 | 100 | $277 | 1.6% |
| 2 | $2.78 | 100 | $278 | 1.6% |
| 3 | $2.84 | 5,000 | $14K | 80.2% |
| 4 | $2.95 | 1,000 | $3K | 16.7% |
| Total | $2.86 avg | 6,200 | $18K | 100% |
| Filing → |
| BRTX | BUY | 2024-02-09 | $325K | — | Filing → |
| BRTX | SELL | 2023-12-05 | $470 | — | Filing → |
| BRTX | SELL | 2023-12-01 | $525 | — | Filing → |